Text Size
60 studies found for:    "Carcinoma, Small Cell"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
21 Completed Survival in a Randomized Phase III Trial in Patients With Limited Disease (LD) Small Cell Lung Cancer Vaccinated With Adjuvant BEC2 and BCG
Condition: Carcinoma, Small Cell Lung
Intervention: Biological: BEC2 Vaccine
22 Recruiting N-AcetylCysteine vs. Placebo to Prevent Neurotoxicity Induced by Platinum Containing Chemotherapy
Conditions: Carcinoma, Non-Small-Cell Lung;   Carcinoma, Small Cell Lung;   Mesothelioma
Interventions: Drug: N-Acetylcysteine;   Drug: Placebo
23 Completed Irinotecan, Carboplatin, Bevacizumab, and Radiation Therapy in the Treatment of Limited Stage Small Cell Lung Cancer
Conditions: Carcinoma, Small Cell Lung;   Lung Cancer
Interventions: Drug: irinotecan;   Drug: carboplatin;   Drug: bevacizumab;   Procedure: Radiation Therapy
24 Recruiting Metabolomic Analysis of Lung Cancer
Conditions: Carcinoma, Non-Small Cell Lung;   Carcinoma, Small Cell Lung
Intervention: Other: 13-C-glucose
25 Completed Irinotecan, Carboplatin, Bevacizumab in the Treatment of Patients With Extensive Stage Small Cell Lung Cancer
Condition: Carcinoma, Small Cell Lung
Interventions: Drug: irinotecan;   Drug: carboplatin;   Drug: bevacizumab
26 Recruiting Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic Malignancies
Conditions: Carcinoma, Non-Small-Cell Lung;   Carcinoma, Small Cell Lung;   Carcinoma, Thymic
Interventions: Drug: AZD;   Drug: MK-2206;   Drug: Lapatinib;   Drug: Erlotinib;   Drug: Sunitinib;   Procedure: Molecular Profiling
27 Completed The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy
Conditions: Anemia;   Multiple Myeloma;   Lymphoma;   Breast Cancer;   Ovarian Cancer;   Carcinoma, Small Cell Lung;   Esophagus Cancer;   Prostate Cancer;   Neoplasm
Intervention: Drug: epoetin alfa
28 Terminated Safety and Efficacy Study of Glufosfamide in Patients With Recurrent Sensitive Small Cell Lung Carcinoma
Condition: Carcinoma, Small Cell Lung
Intervention: Drug: Glufosfamide
29 Completed Safety and Efficacy Study of a New Chemotherapy Agent to Treat Small Cell Lung Cancer
Condition: Carcinoma, Small Cell Lung
Intervention: Drug: Epothilone (BAY86-5302, SH Y03757A)
30 Recruiting Study of Relationship Between UGT1A1 Gene Polymorphism and Toxicity and Efficacy of Irinotecan in Small Cell Lung Cancer
Condition: Small Cell Carcinoma of Lung
Intervention: Drug: Irinotecan
31 Recruiting Cabozantinib for Advanced Urothelial Cancer
Conditions: Micropapillary Cancer of the Bladder;   Squamous Cell Carcinoma of the Bladder;   Bladder Cancer With Bone Metastases;   Bladder Cancer;   Small Cell Cancer of the Bladder;   Urachal Cancer;   Sarcomatoid Bladder Cancer
Interventions: Drug: Cabozantinib;   Procedure: FDG PET CT;   Procedure: NaF PET CT
32 Terminated Study of ACE-011 to Determine Safe and Effective Dose of ACE-011 for the Treatment of Chemotherapy Induced Anemia in Patients With Advanced Non-small Cell Lung Cancer
Conditions: Anemia;   Carcinoma, Non-Small-Cell Lung;   Carcinoma, Small-Cell Lung;   Bladder Cancer;   Cancer of Head and Neck;   Uterine Cervical Cancer
Interventions: Drug: ACE-011 - 15 mg;   Drug: ACE-011 - 30 mg;   Drug: ACE-011 - 45 mg
33 Recruiting Prophylactic Cranial Irradiation (PCI) for Small Cell Carcinoma of the Urothelium
Condition: Bladder Cancer
Interventions: Radiation: Prophylactic Cranial Irradiation (PCI);   Other: Brain X-ray
34 Completed Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural Malignancies
Conditions: Small Cell Carcinoma;   Mesothelioma;   Non-Small-Cell Lung Carcinoma
Interventions: Drug: Decitabine;   Drug: Depsipeptide
35 Suspended Phase I Study of Weekly Topotecan in Combination With Sorafenib in Treatment of Relapsed Small Cell Lung Cancer
Conditions: Small Cell Carcinoma;   Lung Cancer
Interventions: Drug: Topotecan;   Drug: Sorafenib
36 Recruiting Population-Based Stomach Cancer Registry
Conditions: Primary Stomach Carcinoma:;   Adenocarcinoma;   Papillary Adenocarcinoma;   Tubular Adenocarcinoma;   Mucinous Adenocarcinoma;   Signet-ring Cell Carcinoma;   Adenosquamous Carcinoma;   Squamous Cell Carcinoma;   Small Cell Carcinoma;   Undifferentiated Carcinoma;   Other (Specify);   Or Primary:;   Esophagogastric Junction Carcinoma;   Neuroendocrine Tumors;   GiST;   LNH
Intervention: Behavioral: Questionnaire
37 Completed Cone Beam CT Scanning in Lung and Bladder Cancer.
Conditions: Lung Neoplasm;   Small Cell Carcinoma;   Bladder Carcinoma
Intervention:
38 Completed Hypofractionated Radiotherapy for Limited Stage Small Cell Lung Cancer
Conditions: Lung Neoplasm;   Small Cell Carcinoma
Intervention: Radiation: Hypofractionated Chest Radiotherapy
39 Suspended Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer
Conditions: Cervical Adenocarcinoma;   Cervical Adenosquamous Cell Carcinoma;   Cervical Small Cell Carcinoma;   Cervical Squamous Cell Carcinoma;   Recurrent Cervical Cancer;   Stage III Cervical Cancer;   Stage IVA Cervical Cancer;   Stage IVB Cervical Cancer
Interventions: Drug: veliparib;   Drug: topotecan hydrochloride;   Biological: filgrastim;   Biological: pegfilgrastim;   Other: laboratory biomarker analysis
40 Recruiting Fludeoxyglucose F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer
Conditions: Cervical Adenocarcinoma;   Cervical Adenosquamous Cell Carcinoma;   Cervical Small Cell Carcinoma;   Cervical Squamous Cell Carcinoma;   Endometrial Clear Cell Carcinoma;   Endometrial Papillary Serous Carcinoma;   Stage I Endometrial Carcinoma;   Stage IB Cervical Cancer;   Stage II Endometrial Carcinoma;   Stage IIA Cervical Cancer;   Stage IIB Cervical Cancer;   Stage III Cervical Cancer;   Stage III Endometrial Carcinoma;   Stage IVA Cervical Cancer
Interventions: Drug: ferumoxtran-10;   Procedure: diagnostic lymphadenectomy;   Procedure: axillary lymph node biopsy;   Procedure: 3-Tesla magnetic resonance imaging;   Procedure: positron emission tomography/computed tomography;   Radiation: fludeoxyglucose F 18
To Top

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
† Indicates status has not been verified in more than two years